Clinical Trials Browser

Phase 3 × Esophageal Neoplasms × pertuzumab × Clear all

NCT05188313 2022-06-24

TRAP-2

Phase 3 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms